Multi-Pulse Electroporation for Immune Cell Transfection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current electroporation methods for mammalian cells, including NK cells, lack predictability and often result in low viability and a trade-off between transfection efficiency and cell survival, with existing protocols providing large parameter ranges that are not optimized for specific cell types.

Innovation Solution

The use of multiple pulses with moderate voltage, short time constants, and moderate capacitance in an isotonic medium to achieve high-efficiency transfection of immune competent cells, such as NK cells, with RNA, optimizing conditions like field strength, pulse number, and capacitance to maintain high viability and transfection efficiency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If single pulse electroporation is used with conventional parameters, then transfection can be achieved, but transfection efficiency is low and cell viability suffers

Engineering Contradiction:
Improvetransfection efficiencyVSAvoidcell viability
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The electroporation process is divided into multiple pulses (typically 3-10 pulses) rather than using a single pulse. Each pulse delivers a controlled amount of energy to create pores in the cell membrane, allowing nucleic acid entry. This segmentation enables cumulative transfection effect while distributing the stress on cells across multiple shorter events, improving both efficiency and viability

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses periodic electrical pulses with specific inter-pulse intervals (typically 10-100 milliseconds between pulses). This periodic action allows the membrane to partially recover between pulses while maintaining pore formation, enabling repeated nucleic acid uptake events that increase overall transfection efficiency without causing irreversible membrane damage

Inventive Principle:
Principle #19Periodic action

Solution Approach 3:

The invention optimizes multiple parameters simultaneously: pulse duration (5-50 microseconds), field strength (0.5-3 kV/cm), number of pulses (3-10), and inter-pulse interval (10-100 ms). By systematically adjusting these parameters, the method achieves high transfection efficiency while maintaining cell viability above 80%, resolving the traditional trade-off between these two critical outcomes

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If high field strength is used to increase transfection efficiency, then more cells take up nucleic acid, but cell viability decreases

Engineering Contradiction:
Improvetransfection efficiencyVSAvoidcell damage
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

Instead of applying one high-intensity pulse that causes excessive membrane disruption and cell death, the total electroporation effect is segmented into multiple lower-intensity pulses. Each pulse creates sufficient pores for nucleic acid entry, but the distributed energy delivery prevents catastrophic membrane rupture, maintaining cell viability while achieving high transfection efficiency

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention applies partial action by using multiple pulses at moderate field strengths rather than a single excessive pulse. The cumulative effect of multiple moderate pulses achieves the desired transfection level without the harmful effects of excessive single-pulse energy input, balancing efficiency gains with cell survival

Inventive Principle:
Principle #16Partial or excessive action

3Ease of manufacture

If conventional electroporation protocols are used, then transfection can be performed, but parameters are not predictable and require large parameter ranges

Engineering Contradiction:
Improveprotocol simplicityVSAvoidparameter predictability
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The invention establishes specific, optimized parameter ranges that provide predictable outcomes: pulse duration of 5-50 microseconds, field strength of 0.5-3 kV/cm, 3-10 pulses with 10-100 ms intervals. These defined parameters eliminate the need to test broad parameter ranges, making the protocol both simple to implement and predictable in outcome across different cell types

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The optimized multi-pulse protocol demonstrates universality by achieving high transfection efficiency and cell viability across multiple cell types including NK cells, T cells, and other immune competent cells. This universal applicability simplifies protocol development for different applications while maintaining parameter predictability

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach achieves transfection efficiencies above 70% with viability exceeding 80%, with optimal conditions identified for time constant and injected charge, demonstrating robustness across varying cell densities and conductive media, thereby improving the balance between transfection efficiency and cell viability.

Implementation Method 1

Electroporation is a well-known technology used to transfect a wide variety of cell types, typically with nucleic acid molecules, using application of a controlled direct current (DC) electrical pulse for a relatively short duration of time. The pulse is thought to induce a transmembrane potential that causes a reversible breakdown of the ordered structure of a cell membrane, leading to the formation of pores in the membrane.

Methodology Applied
Scientific EffectElectroporation:

Data Source

PatentUS20240209384A1Multi-Pulse Transfection Methods And Cells
Publication Date: 2024.06.27 NANTBIOSCIENCE INC
  • US20240209384A1 patent drawing
  • US20240209384A1 patent drawing

AI summary

Systems and methods are provided for transfecting immune competent cells with RNA at high efficiency and viability.